[{"address1": "4000 Shoreline Court", "address2": "Suite 300", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 822 5600", "website": "https://www.kezarlifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor that is in Phase 2b clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; Phase 1b clinical trials in systemic lupus erythematosus; and completed Phase 2a clinical trials in lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher J. Kirk Ph.D.", "age": 51, "title": "Co-Founder, CEO & Director", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 644685, "exercisedValue": 0, "unexercisedValue": 5485}, {"maxAge": 1, "name": "Mr. John Franklin Fowler", "age": 52, "title": "Co-Founder & Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 539349, "exercisedValue": 0, "unexercisedValue": 2641}, {"maxAge": 1, "name": "Mr. Marc L. Belsky CPA", "age": 69, "title": "CFO & Secretary", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 639413, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack  Taunton Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gitanjali  Jain", "title": "Senior Vice President of Investor Relations & External Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Schiller", "age": 44, "title": "Chief Legal Officer", "yearBorn": 1980, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joe  Tedrick", "title": "Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neel K. Anand Ph.D.", "title": "Senior Vice President of Research & Drug Discovery", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Zung  To", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pattie  Chiang", "title": "Senior VP & Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 9, "overallRisk": 10, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.5, "open": 4.465, "dayLow": 3.6201, "dayHigh": 4.465, "regularMarketPreviousClose": 4.5, "regularMarketOpen": 4.465, "regularMarketDayLow": 3.6201, "regularMarketDayHigh": 4.465, "payoutRatio": 0.0, "beta": 0.609, "forwardPE": -0.39350525, "volume": 69288, "regularMarketVolume": 69288, "averageVolume": 31038, "averageVolume10days": 47140, "averageDailyVolume10Day": 47140, "bid": 3.04, "ask": 4.65, "bidSize": 1, "askSize": 2, "marketCap": 30099896, "fiftyTwoWeekLow": 3.62, "fiftyTwoWeekHigh": 9.2, "fiftyDayAverage": 5.83, "twoHundredDayAverage": 6.47865, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -85965104, "profitMargins": 0.0, "floatShares": 4914027, "sharesOutstanding": 7305800, "sharesShort": 60447, "sharesShortPriorMonth": 120601, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0083, "heldPercentInsiders": 0.11987001, "heldPercentInstitutions": 0.61952996, "shortRatio": 2.21, "shortPercentOfFloat": 0.0085, "impliedSharesOutstanding": 7305800, "bookValue": 16.008, "priceToBook": 0.2573713, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -83736000, "trailingEps": -11.49, "forwardEps": -10.47, "lastSplitFactor": "1:10", "lastSplitDate": 1730246400, "enterpriseToEbitda": 0.976, "52WeekChange": -0.49135804, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 4.12, "targetHighPrice": 18.0, "targetLowPrice": 7.0, "targetMeanPrice": 12.5, "targetMedianPrice": 12.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 132245000, "totalCashPerShare": 18.101, "ebitda": -88095000, "totalDebt": 16180000, "quickRatio": 6.526, "currentRatio": 6.763, "debtToEquity": 13.839, "returnOnAssets": -0.30449, "returnOnEquity": -0.55002, "grossProfits": -65742000, "freeCashflow": -45235000, "operatingCashflow": -74212000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KZR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "shortName": "Kezar Life Sciences, Inc.", "longName": "Kezar Life Sciences, Inc.", "regularMarketChangePercent": -8.4444475, "regularMarketPrice": 4.12, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "marketState": "CLOSED", "regularMarketChange": -0.3800001, "regularMarketDayRange": "3.6201 - 4.465", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 31038, "fiftyTwoWeekLowChange": 0.5, "fiftyTwoWeekLowChangePercent": 0.13812155, "fiftyTwoWeekRange": "3.62 - 9.2", "fiftyTwoWeekHighChange": -5.08, "fiftyTwoWeekHighChangePercent": -0.5521739, "fiftyTwoWeekChangePercent": -49.135803, "earningsTimestamp": 1742905800, "earningsTimestampStart": 1746648000, "earningsTimestampEnd": 1747080000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -11.49, "epsForward": -10.47, "epsCurrentYear": -9.3, "priceEpsCurrentYear": -0.44301072, "fiftyDayAverageChange": -1.71, "fiftyDayAverageChangePercent": -0.29331046, "regularMarketTime": 1743796801, "exchange": "NCM", "messageBoardId": "finmb_304157325", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "twoHundredDayAverageChange": -2.3586502, "twoHundredDayAverageChangePercent": -0.36406508, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "displayName": "Kezar Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]